Search

everythinglearnresearchcommunity

for

Search:↓

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Balding and low testosterone increase risk of urinary stones.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Early balding may be a sign of future prostate problems.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Testosterone is vital for male health, and its deficiency is linked to aging and common health issues.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Testosterone may influence COVID-19 severity and outcomes.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

Finasteride effectively treats baldness but may cause sexual side effects.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Lespedeza cuneata extract may help treat enlarged prostate.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The book explains causes and treatments for common hair loss, its psychological effects, related health risks, and emphasizes early screening and lifestyle changes.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.